SENATE-BILL 854: S.854 - Risky Research Review Act
AI-Powered Summary
SENATE-BILL 854 establishes the Life Sciences Research Security Board to evaluate and determine eligibility for federal funding in high-risk life sciences research. The bill aims to enhance national security and public health by regulating research that poses significant risks, while potentially impacting researchers' constitutional rights, including freedom of speech, due process, and equal protection. Key provisions include the board's authority to define 'high-risk' research, which may limit funding opportunities and require disclosure of participation in such research, raising privacy concerns. The implementation of this legislation may lead to significant changes in the funding landscape for scientific research, influencing the direction of innovation and inquiry. Potential implications include increased scrutiny and regulation of life sciences research, which could foster a more secure research environment but may also lead to arbitrary decision-making and discrimination against certain research areas, thus affecting the overall research ecosystem.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The bill's establishment of a regulatory board for life sciences research introduces potential infringements on individual rights, particularly in the realms of free speech, due process, and equal protection. The oversight mechanisms may lead to censorship of research and arbitrary funding decisions, which could disproportionately impact marginalized groups.
Key Individual Rights Affected
- First Amendment (free speech and academic freedom)
- Fifth Amendment (due process)
- Fourteenth Amendment (equal protection)
Constitutional Provisions Most Relevant
- First Amendment
- Fifth Amendment
- Fourteenth Amendment
Potential Constitutional Challenges Or Support
Challenges
- Censorship of research findings deemed sensitive or controversial
- Arbitrary application of funding criteria leading to discrimination
- Due process concerns regarding the review process and funding denials
Support
- Enhanced public safety and accountability in federal funding decisions
- Transparency in research funding allocation
Summary
SENATE-BILL 854 aims to enhance oversight of high-risk life sciences research but raises significant constitutional concerns regarding individual rights. The potential for censorship, arbitrary decision-making, and unequal treatment under the law could infringe upon fundamental rights, necessitating careful scrutiny to ensure that the bill's implementation does not violate constitutional protections.
Constitutional Analysis
This bill has been analyzed for constitutional compliance using AI-powered analysis of constitutional principles and precedents.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention S. 854 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreePolicy Topics
Timeline
March 5, 2025
Bill Introduced
Current
Reported by Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat